Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises Preparing for Resubmission Over Formal Dispute
- Upcoming Trial Readouts to Watch
- Lykos Prioritises Preparing for Resubmission Over Formal Dispute
- Other Stories
- Bogenschutz Scores $3.8m NIAAA Grant for Psilocybin in Alcohol Use Disorder Study
- FDA Issues Decentralised Clinical Trials Guidance
- New Mental Health Parity Regs Come Into Force in January 2025
- More Headlines
Upcoming Trial Readouts to Watch
As the news cycle becomes less consumed by Lykos (though, there is a short piece below), we’re looking ahead to upcoming sponsored psychedelic trial readouts slated for the next two or three quarters. Here is a selection to look out for…
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In